Sphere Fluidics

Brand Category: 
Description: 
Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge. We’ve already developed 25 patented products – biochips and specialist chemicals – which are assisting over 220 customers globally with their research. For the last 4 years we have been developing Cyto-Mine®. Cyto-Mine® is the world’s first The Single Cell Analysis & Monoclonality Assurance System. It is the next generation platform that will transform biopharmaceutical discovery and cell line development workflows. It is specifically designed to automatically perform: high-throughput single cell encapsulation, incubation then protein secretion assays, rapid cell sorting, dispensing of ‘hit’ single cells into individual wells of 96- or 384-well MTPs and imaging / monoclonality verification.
Country: 
UK